Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00315_DB00780_nanopub.RAd18z6fyv_3q65TzQmC-T478UemYywZX2Bkm2ohchMPY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00315_DB00780 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00315_DB00780 label "DDI between Zolmitriptan and Phenelzine - The MAO inhibitor, phenelzine, may increase the serum concentration of zolmitriptan by decreasing its metabolism. Concomitant therapy and use of zolmitriptan within two weeks of discontinuing phenelzine are contraindicated. [drugbank_resource:DB00315_DB00780]" assertion.
- drugbank_resource:DB00315_DB00780 identifier "drugbank_resource:DB00315_DB00780" assertion.
- drugbank_resource:DB00315_DB00780 title "DDI between Zolmitriptan and Phenelzine - The MAO inhibitor, phenelzine, may increase the serum concentration of zolmitriptan by decreasing its metabolism. Concomitant therapy and use of zolmitriptan within two weeks of discontinuing phenelzine are contraindicated." assertion.
- drugbank:DB00780 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB00780 assertion.
- drugbank:DB00315 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB00780 assertion.